Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393
- 9 March 1996
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 347 (9002), 635-639
- https://doi.org/10.1016/s0140-6736(96)91200-3
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Direct Thrombin Inhibition with Rec-Hirudin CGP 39393 as Prophylaxis of Thromboembolie Complications after Total Hip ReplacementThrombosis and Haemostasis, 1994
- A Comparison of Subcutaneous Low-Molecular-Weight Heparin with Warfarin Sodium for Prophylaxis against Deep-Vein Thrombosis after Hip or Knee ImplantationNew England Journal of Medicine, 1993
- Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysisThe Lancet, 1992
- Phlebographic findings in venous thrombosis following total hip replacementActa Radiologica, 1990
- Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous HeparinNew England Journal of Medicine, 1988
- Antithrombotic and haemorrhagic effects of synthetic and naturally occurring thrombin inhibitorsThrombosis Research, 1986
- Pulmonary Angiography, Ventilation Lung Scanning, and Venography for Clinically Suspected Pulmonary Embolism with Abnormal Perfusion Lung ScanAnnals of Internal Medicine, 1983
- Is Embolic Risk Conditioned By Location of Deep Venous Thrombosis?Annals of Internal Medicine, 1981
- Ventilation-perfusion studies in suspected pulmonary embolismAmerican Journal of Roentgenology, 1979
- Roentgen Diagnosis of Venous Thrombosis in the LegArchives of Surgery, 1972